Stockscreener 앱 받기
13.72
1.86%
-0.26
시장 영업 전:
13.37
-0.35
-2.55%
Tonix Pharmaceuticals Holding Corp 주식(TNXP)의 최신 뉴스
TNXP: Tonix Pharmaceuticals Shares Promising Results from Clinical Studies - GuruFocus
TONMYA fibromyalgia tablet under tongue bypasses first-pass liver metabolism - Stock Titan
Tonix Pharmaceuticals: Tonmya launches for fibromyalgia as pipeline advances toward key 2027 milestones - TradingView
Tonix Pharmaceuticals to Present Poster on Tonmya at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting - Bitget
New fibromyalgia treatment Tonmya shows gains in patient outcomes poster - Stock Titan
Tonix Pharma Uplists to Nasdaq Global Select Market - TipRanks
Tonix Pharmaceuticals announces uplisting from Nasdaq Capital Market to Nasdaq Global Select Market - marketscreener.com
Tonix Pharmaceuticals Moves Listing to Nasdaq Global Select Market - marketscreener.com
Tonix Pharmaceuticals (TNXP) Moves to Nasdaq Global Select Marke - GuruFocus
Tonix Pharmaceuticals moves to Nasdaq Global Select Market - Investing.com
Tonix Pharmaceuticals approved to transfer listing to Nasdaq Global Select Market - TradingView
Tonix Pharmaceuticals (NASDAQ: TNXP) uplists to Nasdaq Global Select tier - Stock Titan
Tonix Pharmaceuticals Announces Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market - GlobeNewswire
Avoiding Lag: Real-Time Signals in (TNXP) Movement - Stock Traders Daily
Tonix Pharmaceuticals to Present Clinical Trial Data on Fibromyalgia Drug Tonmya at 2026 AAPM PainConnect Meeting - geneonline.com
Tonix Pharmaceuticals : March 2026 Investor Deck - marketscreener.com
Tonix Pharmaceuticals to Participate in Two Investor Conferences in March - Sahm
TNXP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Tonix (TNXP) COO awarded two stock option grants under 2020 plan - Stock Titan
Tonix (TNXP) CFO granted stock options with multi-year vesting - Stock Titan
Tonix Pharmaceuticals (TNXP) CMO granted two new stock option awards - Stock Titan
Tonix Pharmaceuticals (TNXP) CTO receives two new stock option grants - Stock Titan
Tonix Pharmaceuticals (TNXP) CEO awarded new multi-year stock option grants - Stock Titan
TNXP Stock Price, Forecast & Analysis | TONIX PHARMACEUTICALS HOLDIN (NASDAQ:TNXP) - ChartMill
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences in March 2026 - Quiver Quantitative
Fibromyalgia drug maker Tonix to brief investors at March conferences - Stock Titan
Tonix Pharmaceuticals: Financial Runway and Pipeline Progress Under Scrutiny - AD HOC NEWS
Discipline and Rules-Based Execution in TNXP Response - Stock Traders Daily
Is Tonix Pharmaceuticals Holding Corp. forming a breakout pattern2025 Breakouts & Breakdowns & Weekly Watchlist of Top Performers - mfd.ru
Aug Catalysts: Will Tonix Pharmaceuticals Holding Corp announce a stock split2025 Technical Patterns & Daily Volume Surge Trade Alerts - baoquankhu1.vn
What is the PEG ratio of Tonix Pharmaceuticals Holding Corp.2025 Volatility Report & Accurate Entry and Exit Point Alerts - mfd.ru
TNXP PE Ratio & Valuation, Is TNXP Overvalued - Intellectia AI
What are Tonix Pharmaceuticals Holding Corp.’s earnings expectationsSwing Trade & Community Trade Idea Sharing Platform - mfd.ru
TNXP News Today | Why did Tonix Pharmaceuticals stock go up today? - MarketBeat
Behavioral Patterns of TNXP and Institutional Flows - Stock Traders Daily
Market Recap: Will Tonix Pharmaceuticals Holding Corp stock benefit from M APortfolio Value Report & Safe Capital Growth Stock Tips - baoquankhu1.vn
Earnings Recap: Can Tonix Pharmaceuticals Holding Corp deliver alphaJuly 2025 Opening Moves & Verified Momentum Stock Ideas - baoquankhu1.vn
Dying for Some Sleep - RealClearHealth
Tonix Pharmaceuticals (TNXP) outlines preliminary 2025 figures and cash runway into 2027 - Stock Titan
Tonix opens Berkeley Heights HQ, expands NJ biotech footprint - NJBIZ
Aug Opening: How volatile is Haverty Furniture Companies Inc stockPortfolio Risk Report & Verified High Yield Trade Plans - baoquankhu1.vn
Tonix’s fibromyalgia drug shows significant pain reduction in study By Investing.com - Investing.com Australia
Tonix Highlights Significant Phase 3 RESILIENT Results For TONMYA At Non-Opioid Pain Summit - Nasdaq
Tonix Presents Positive Phase 3 RESILIENT Data On TONMYA At 2026 Non-Opioid Pain Therapeutics Summit - Nasdaq
Tonix Pharmaceuticals (TNXP) Reports Positive Phase 3 Trial Resu - GuruFocus
Tonix’s fibromyalgia drug shows significant pain reduction in study - Investing.com
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit - The Manila Times
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on - GlobeNewswire
Pharma company Tonix opening HQ in Berkeley Heights - ROI-NJ
Fibromyalgia Market: Expanding Revenue Landscape to 2034 – DelveInsight | UCB Pharma, Eli Lilly and Company, Merck, Aptinyx, Astellas Pharma, Tonix Pharma, UCB Biopharma SRL, GSK, UCB Pharma - Barchart.com
(TNXP) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
A. G. P. Maintains Tonix Pharmaceuticals(TNXP.US) With Buy Rating, Maintains Target Price $65 - 富途牛牛
Trend Review: Is now the right time to enter Tonix Pharmaceuticals Holding CorpEarnings Overview Report & High Return Trade Guides - baoquankhu1.vn
Aug Wrap: Is Tonix Pharmaceuticals Holding Corp forming a breakout patternJuly 2025 Trade Ideas & Reliable Breakout Stock Forecasts - baoquankhu1.vn
BlackRock (TNXP holder) reports 6.7% Tonix Pharmaceuticals stake in 13G/A - Stock Titan
Tonix Eyes TNX‑102 SL Expansion, But We Need To See Tonmya Revenue First (NASDAQ:TNXP) - Seeking Alpha
How (TNXP) Movements Inform Risk Allocation Models - Stock Traders Daily
Returns Recap: Will Tonix Pharmaceuticals Holding Corp stock benefit from M A2025 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Market Fear: Can Tonix Pharmaceuticals Holding Corp stock outperform in a bear market2025 Top Decliners & Comprehensive Market Scan Reports - baoquankhu1.vn
Tonix Pharmaceuticals (NASDAQ:TNXP) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Aug PostEarnings: What are Tonix Pharmaceuticals Holding Corps earnings expectationsWeekly Volume Report & Detailed Earnings Play Strategies - baoquankhu1.vn
Analyst Downgrade: Will Tonix Pharmaceuticals Holding Corp face regulatory challengesJuly 2025 Momentum & Technical Confirmation Alerts - baoquankhu1.vn
Fibromyalgia Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates - openPR.com
Block Trades: What is the fair value of Tonix Pharmaceuticals Holding Corp. stock now2025 Key Highlights & Reliable Intraday Trade Plans - moha.gov.vn
How rising interest rates impact Tonix Pharmaceuticals Holding Corp. stockBreakout Watch & Verified Momentum Watchlists - Улправда
3.69%
0.68%
자본화:
|
볼륨(24시간):